Desmoid Tumors (Aggressive Fibromatosis)

Desmoid Tumors (Aggressive Fibromatosis), explained simply

Everything a patient or caregiver wants to understand: what desmoid tumors (aggressive fibromatosis) is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is desmoid tumors (aggressive fibromatosis)?

Desmoid tumors, also called aggressive fibromatosis, are rare growths that arise from the connective tissue — the fibrous tissue that forms tendons, ligaments, and the coverings of muscles. They are unusual because they sit in a gray zone: they are not cancer and do not spread to distant parts of the body the way cancers do, yet they can grow into and invade nearby muscles, nerves, and organs, sometimes causing pain, loss of function, or — depending on location — serious complications. They can appear almost anywhere, commonly in the abdominal wall, inside the abdomen, or in the limbs, shoulders, and chest wall. Some develop after surgery, injury, or pregnancy, and a subset occur in people with an inherited condition called familial adenomatous polyposis (FAP), where desmoids inside the abdomen are an important concern. The behavior of desmoid tumors is famously unpredictable: some grow, some stay stable for years, and a notable number actually shrink on their own without any treatment. Because of this, the modern approach has shifted away from rushing to operate. Many patients are now monitored with periodic scans — an approach called active surveillance — and treatment is reserved for tumors that grow, cause symptoms, or threaten important structures. When treatment is needed, the choices have expanded to include newer targeted medicines, other systemic therapies, surgery, and radiation, chosen based on the tumor's location, size, and how it is behaving.

In one line: Desmoid tumors are non-cancerous but locally invasive growths of connective tissue; many are simply watched, and when treatment is needed, options now include newer targeted medicine, surgery, and radiation for tumors that cannot be removed.

The main types

Doctors group desmoid tumors (aggressive fibromatosis) by where it starts and how it behaves:

TypeWhat it means, simply
Abdominal wall desmoidLocated in the muscles of the abdominal wall, often in young adults and sometimes after pregnancy; generally has the most favorable course and is frequently watched or removed surgically with good results.
Intra-abdominal desmoidLocated inside the abdomen, including around the bowel and its blood supply; can be more challenging because of nearby vital structures, and is common in people with familial adenomatous polyposis (FAP).
Extra-abdominal desmoidLocated in the limbs, shoulder, chest wall, or head and neck; treatment weighs preserving function against controlling a tumor that can invade muscle and nerves.
FAP-associated desmoidOccurs in people with the inherited condition familial adenomatous polyposis; these tumors warrant coordination with genetics and the team managing the underlying syndrome.

Staging, in plain terms

Desmoid tumors are not staged like cancers, because they do not spread to distant organs and are not malignant in the usual sense. Instead, doctors describe and manage them based on a few practical factors. The most important is location, because a desmoid in the abdominal wall behaves and is treated very differently from one wrapped around the bowel or sitting next to a major nerve. Size and rate of growth matter too: a stable tumor causing no symptoms is very different from one that is enlarging or pressing on something important. Symptoms — pain, loss of movement, or interference with an organ — strongly influence whether and how to treat. Doctors also consider whether the tumor is associated with the inherited FAP syndrome, since that changes the broader plan. Because desmoids are so unpredictable — some grow, some stay the same, and some shrink on their own — the first step for many patients is careful monitoring rather than immediate treatment, with scans over time showing how the tumor is actually behaving before deciding what to do.

No cancer staging system — managed by location, size, symptoms, and whether the tumor is growingWhat it generally means
Stable or shrinking, no symptomsA tumor that is not growing and causes no problems; usually managed with active surveillance — periodic scans and exams — because many desmoids stay stable or shrink without any treatment.
Growing or symptomaticA tumor that is enlarging, causing pain, or limiting function; treatment is started, choosing among targeted or other medication, surgery, or radiation based on location and goals.
Threatening vital structuresA tumor pressing on or invading important structures (such as the bowel, major blood vessels, or nerves); treated more urgently, often with systemic medicine and a coordinated plan to protect function.
Recurrent after surgeryA tumor that has come back after removal; because desmoids can recur, treatment may shift toward medication or radiation rather than repeat surgery.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Desmoid Tumors (Aggressive Fibromatosis) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Active surveillance

For many tumors causing no symptoms, the best first step is watchful monitoring with periodic scans, since a substantial number of desmoids stay stable or shrink on their own, avoiding unnecessary treatment.

Targeted medication

Newer targeted therapy — including a recently approved oral medicine (a gamma-secretase inhibitor) for desmoid tumors needing systemic treatment — can shrink tumors and relieve symptoms while avoiding surgery.

Other systemic therapies

Hormone-blocking drugs, anti-inflammatory medicines, certain targeted kinase inhibitors, or low-dose chemotherapy are options used depending on the tumor and patient.

Surgery

Removal is still useful for selected tumors, especially in the abdominal wall, though doctors now weigh it carefully because desmoids can recur and surgery can affect function.

Radiation therapy

Used for tumors that cannot be removed, that recur, or where surgery would cause too much harm; it can stop growth and shrink the tumor over time while preserving the surrounding structures.

How radiation treatment works

Radiation therapy uses focused high-energy beams to damage the DNA inside tumor cells so they lose the ability to grow and divide. Even though desmoid tumors are not cancer, the cells that drive their relentless local growth are sensitive to radiation, which is why radiation can be an effective way to control a desmoid that cannot be safely removed by surgery, that has come back, or that sits where an operation would cause too much harm. Unlike treatment for many cancers, the response is often gradual: radiation tends to stop the tumor from growing first, and then the tumor slowly shrinks over months. Because desmoids frequently sit right next to muscles, nerves, the bowel, and other structures that must be preserved, precision is essential. Modern planning with intensity-modulated radiation shapes the dose tightly around the tumor while sparing surrounding healthy tissue, and proton therapy — where available — can further limit the dose to tissue beyond the target, which is especially valuable near sensitive structures or in younger patients. Radiation may be used on its own for an unresectable tumor, or after surgery when the risk of return is high. As with all radiation, treatment is planned to balance controlling the tumor against protecting long-term function and minimizing side effects. Because the modern approach to desmoids increasingly favors watchful monitoring and newer targeted medicines first, radiation is chosen thoughtfully, for the situations where it offers the clearest benefit.

The main ways radiation is delivered for desmoid tumors (aggressive fibromatosis):

Definitive external-beam radiation

For a desmoid that cannot be safely removed or has recurred, focused external-beam radiation delivers a moderate dose over several weeks to halt growth and gradually shrink the tumor, often achieving durable local control without surgery.

Radiation after surgery

When a tumor is removed but margins are incomplete or the risk of return is high, radiation to the surgical area can lower the chance of recurrence.

Intensity-modulated radiation (IMRT)

Shaping the radiation beams tightly around the tumor protects nearby muscles, nerves, bowel, and other tissues — important because desmoids often sit next to structures that must be preserved.

Proton therapy in selected cases

Where available, proton beams can spare healthy tissue beyond the tumor, useful for desmoids near sensitive structures or in younger patients where limiting lifetime radiation exposure matters.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

Targeted oral therapy approved for desmoid tumors: A selective gamma-secretase inhibitor (nirogacestat) was shown in a randomized trial to significantly improve progression-free survival, tumor response, and quality of life, and is now approved for adults with progressing desmoid tumors needing systemic treatment — recently gaining European approval in 2025 in addition to earlier U.S. approval.[1]

DeFi trial and regulatory approvals (2023–2025)

Active surveillance validated as first approach: Studies show that many desmoid tumors remain stable or shrink without treatment, supporting a watch-and-wait strategy for tumors that are not causing symptoms and avoiding the risks of unnecessary surgery.[2]

Desmoid active-surveillance cohorts

Radiation achieves durable control for unresectable tumors: Series of patients treated with moderate-dose radiation for desmoids that could not be removed report high rates of long-term local control, with the tumor stabilizing and shrinking over time.[3]

Desmoid radiation outcome studies

Common questions

Is a desmoid tumor cancer? No. Desmoid tumors are not cancer and do not spread to distant organs. However, they are locally aggressive — they can grow into and invade nearby muscles, nerves, and organs, which is why they sometimes need treatment despite being benign.

Why might my doctor recommend just watching it? Desmoid tumors are unpredictable: many stay the same size for years and a meaningful number shrink on their own. Because treatments carry side effects, doctors often monitor a tumor that isn't causing symptoms with periodic scans, reserving treatment for tumors that grow or cause problems. This avoids unnecessary surgery or medication.

When is radiation used instead of surgery? Radiation is a good option when a tumor cannot be safely removed, when it has come back after surgery, or when an operation would damage important structures. It tends to stop growth and shrink the tumor gradually over months while preserving the surrounding tissue, offering durable control without an operation.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. DeFi trial and regulatory approvals (2023–2025) (no indexed identifier — see your care team)
  2. Desmoid active-surveillance cohorts (no indexed identifier — see your care team)
  3. Desmoid radiation outcome studies (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides